Dividends4Life: 3 Biotech Stocks That Pay Solid Dividends

Dividend Growth Stocks News

3 Biotech Stocks That Pay Solid Dividends

Posted by D4L | Thursday, February 28, 2019 | | 0 comments »

First, and perhaps the most obvious, is that being able to enter biotech stocks at a cheaper price — assuming the companies are not fundamentally broken — is much better than going in while the stocks are overpriced or in “rally mode”. Second, in situations like this, companies’ dividend yields go up. What all of this means is that despite the seemingly grim picture for biotech, there are actually several solid biotech dividend stocks to invest in now. The struggle is sifting through all the names and finding which of them are the best dividend stocks to invest in. But don’t worry, I’ve done the hard work for you. Below are three of the best biotech dividend stocks to buy now...

AbbVie (NYSE:ABBV) trades at a modest price-to-earnings ratio of 21X, while shares yield 5.45%. Although short-term investors might be concerned that ABBV shares have been on a downtrend since topping in May 2018 at $122, there is still plenty of longer-term potential in ABBV to be hyped about. Allergan plc (NYSE:AGN) ended its last rally in October 2018, with AGN shares finally bottoming by the end of last year at around $130. The stock fell again from $160 to a recent price of $144 after reporting Q4 results. After settling at around $42 at the start of 2019, Sanofi (NASDAQ:SNY) rallied steadily to close at around $43.45 recently. Now, at its 50-day simple moving average, shares have a dividend yield of 4.28%.

Source: InvestorPlace

Related Articles:
- 10 Dividend Stocks With A 10%+ Dividend Growth Rate
- 3 Styles Of Successful Dividend Investing
- Building Yield: 6 Consumer Goods Dividend Stocks
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends



Post a Comment

Note: Only a member of this blog may post a comment.